BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $109,825 | +22.0% | 115,000 | 0.0% | 0.00% | – |
Q2 2023 | $90,013 | +6.3% | 115,000 | 0.0% | 0.00% | – |
Q1 2023 | $84,640 | +65.4% | 115,000 | 0.0% | 0.00% | – |
Q4 2022 | $51,175 | -24.7% | 115,000 | 0.0% | 0.00% | – |
Q3 2022 | $68,000 | +7.9% | 115,000 | 0.0% | 0.00% | – |
Q2 2022 | $63,000 | -4.5% | 115,000 | 0.0% | 0.00% | – |
Q1 2022 | $66,000 | -21.4% | 115,000 | 0.0% | 0.00% | – |
Q4 2021 | $84,000 | -46.8% | 115,000 | 0.0% | 0.00% | – |
Q3 2021 | $158,000 | -16.4% | 115,000 | 0.0% | 0.00% | – |
Q2 2021 | $189,000 | -0.5% | 115,000 | 0.0% | 0.00% | – |
Q1 2021 | $190,000 | – | 115,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |